EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial defects in the cAMP-PKA-DRP1 pathway in a Crppa deletion model of dystroglycanopathy

Jihang Luo, Yidan Liu, Danyu Song, Shiqi Yang, Xiaona Fu, Lin Ge, Cuijie Wei, Liya Cui, Yanwei He, Jin Xu, Qiang Shen, Yuxuan Guo und 5 weitere

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Jihang Luo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center, Peking University First Hospital, No.5 Le Yuan Road, Daxing District, Beijing 102627, China. Hauptthemen laut MEDLINE: Dynamins, Cyclic AMP-Dependent Protein Kinases, Cyclic AMP, Mitochondria. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital Medical University, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dystroglycanopathies (DGPs) are autosomal recessive muscular dystrophies caused by abnormal α-dystroglycan glycosylation. CRPPA is one causative gene, with deletion of exons 6-9 identified as a founder variant in Chinese patients. Our previous study revealed mitochondrial abnormalities in patient muscle biopsies, although the underlying mechanism(s) remained unclear. A Crppa knockout mouse (dyC/dyC) was generated based on the founder variant, displaying muscle weakness, cerebellar hypoplasia, retinal abnormalities and neonatal lethality within 24 h. Electron microscopy showed mitochondrial structural defects in skeletal muscle, consistent with patient findings. RNA sequencing revealed dysregulation of the cAMP-PKA pathway, accompanied by decreased ATP and reduced phosphorylation of PKA and DRP1 (Ser637). To verify the link between CRPPA deficiency and mitochondrial dysfunction, Crppa knockdown C2C12 cells and CRPPA-related DGP patient-derived fibroblasts were examined. Both models exhibited reduced DRP1 Ser637 phosphorylation and ATP levels. Treatment with cAMP-PKA activators restored DRP1 phosphorylation and ATP production in a time-dependent manner. Recovery of mitochondrial membrane potential was confirmed by JC-1 staining. These findings suggest that CRPPA deficiency is associated with mitochondrial dysfunction involving the cAMP-PKA-DRP1 axis, suggesting a candidate pathway warranting further investigation for DGPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DynaminsCyclic AMP-Dependent Protein KinasesCyclic AMPMitochondriaSignal TransductionGene DeletionDystroglycansMuscular DystrophiesAnimalsHumansPhosphorylationAdenosine TriphosphateDisease Models, AnimalMice, KnockoutMuscle, SkeletalMembrane Potential, MitochondrialFibroblastsCell LineMice

Stichwörter der Autor:innen

CRPPADystroglycanopathiesMitochondrialMouse modelcAMP-PKA-DRP1

Substanzen

DynaminsCyclic AMP-Dependent Protein KinasesCyclic AMPAdenosine TriphosphateDystroglycansDnm1l protein, mouse

Autor:innen und Institutionen

  • Children's Medical Center, Peking University First Hospital, No.5 Le Yuan Road, Daxing District, Beijing 102627, China.
  • Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
  • State Key Laboratory of Vascular Homeostasis and Remodeling, The Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
  • Laboratory of Electron Microscopy, Peking University First Hospital, Beijing 102600, China.
  • Department of Cell Biology and Molecular Medicine, Ehime University Graduate School of Medicine, Shitsukawa 454, Toon, Ehime 791-0295, Japan.
  • Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

ORCID-Profile: Hui Xiong

Förderung

  • Capital Medical University
  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Luo, J., Liu, Y., Song, D., Yang, S., Fu, X., Ge, L., Wei, C., Cui, L., He, Y., Xu, J., Shen, Q., Guo, Y., Kanagawa, M., Toda, T., Wang, J., Zhang, H., & Xiong, H. (2026). Mitochondrial defects in the cAMP-PKA-DRP1 pathway in a Crppa deletion model of dystroglycanopathy. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052890

Vancouver

Luo J, Liu Y, Song D, Yang S, Fu X, Ge L, et al. Mitochondrial defects in the cAMP-PKA-DRP1 pathway in a Crppa deletion model of dystroglycanopathy. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052890

BibTeX
@article{Luo2026,
  author = {Luo, Jihang and Liu, Yidan and Song, Danyu and Yang, Shiqi and Fu, Xiaona and Ge, Lin and Wei, Cuijie and Cui, Liya and He, Yanwei and Xu, Jin and Shen, Qiang and Guo, Yuxuan and Kanagawa, Motoi and Toda, Tatsushi and Wang, Jingmin and Zhang, Hong and Xiong, Hui},
  title = {Mitochondrial defects in the cAMP-PKA-DRP1 pathway in a Crppa deletion model of dystroglycanopathy},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052890}
}
Kostenlos starten →